How big is the Pompe Disease Therapeutics Market ?
The global Pompe disease therapeutics market reached USD 1.3 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 1.9 billion by 2031.
Who are the key players in Pompe Disease Therapeutics Market ?
Major players are Genzyme (Sanofi), Amicus Therapeutics, Valerion Therapeutics, Audentes Therapeutics, Actus Therapeutics, BioMarin Pharmaceutical, EpiVax, Oxyrane, Sangamo BioSciences, Avrobio and Spark Therapeutics.